IMMUNE NETWORK RESEARCH (VSE:IMM) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IMMUNE NETWORK RESEARCH (VSE:IMM)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: pete meyer who wrote (27)	3/7/1997 1:23:00 PM
From: burner	of 134

pete, ------------------------------------------------------------------------ IMMUNE NETWORK RESEARCH - IMM.V, $0.16 HALTED Feb. 11 TO SEEK SHAREHOLDER APPROVAL ON TRANSACTION AT MAY 22 AGM IMM announced it will seek shareholder approval for Bio-Fluorescent Technologies' acquisition of IMM's assets for 9 Million shares of BFTK at the May 22 AGM. The deal looks good for shareholders, and should be approved. As to when IMM shares will trade again is anyone's guess. But if they did now they'd be worth significantly more than where they closed on Feb. 11. BFTK trades at around US$0.45, times 25% for currency = US$0.56 divided by 2 gives you more like C$0.28, double where it last traded. And with the much larger US exposure through its NASDAQ listing, I believe BFTK has good potential to trade higher once the deal gets done, so it may may even pay to hold the shares longer. This was pulled off Louis Paquette's Newsletter. Dan

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next